Overview
The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic
Status:
Unknown status
Unknown status
Trial end date:
2020-12-31
2020-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityTreatments:
Lidocaine
Criteria
Inclusion Criteria:- Patients undergoing single-port thoracoscopic with a left double lumen bronchial
catheter
- Age ≧ 18 years old, ≦70 years old
- Temperature, white blood cells, and hemoglobin were normal before surgery
- Patient informed consent
Exclusion Criteria:
- Patients with a history of surgery within six months
- Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important
organs
- American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
- Allergic to lidocaine
- Bradycardia (heart rate < 60 beats/min) or atrioventricular block
- Mental disorder
- Patients requiring a right double lumen bronchial catheter